Analysis of pathogenesis, syndrome differentiation and treatment of asymptomatic infectors of coronavirus disease 2019 based on the theory of "pathogen hiding in the pleurodiaphragmatic interspace"
10.3760/cma.j.cn121430-20200611-00630
- VernacularTitle:基于"邪伏膜原"理论探讨新型冠状病毒肺炎无症状感染者的发病机制与辨证论治思路
- Author:
Yuming LI
1
;
Jinzhong WANG
;
Xiaolan QIN
;
Yuntao LIU
Author Information
1. 广州中医药大学第二附属医院急诊科，广州 510120；广东省中医院急诊科，广州 510120
- From:
Chinese Critical Care Medicine
2020;32(10):1160-1164
- CountryChina
- Language:Chinese
-
Abstract:
Among coronavirus disease 2019 (COVID-19) patients who infected with 2019 novel coronavirus (2019-nCoV), compared with the symptomatic infection patients, 2019-nCoV carried by asymptomatic infection patients are more likely to be widely spread due to secrecy and neglect, thus brings severe challenges to the current prevention and treatment of COVID-19. The therapies of asymptomatic 2019-nCoV infection are still in research. Through excavating the Chinese medical classics, it was found that the theory of "pathogen hiding in the pleurodiaphragmatic interspace", with its unique syndrome differentiation system and curative effect of treating symptoms and causes, can provide clinical reference for the treatment of asymptomatic 2019-nCoV infections and provide theoretical basis traditional Chinese medicine in the battle against infectious diseases.
